Co-delivery of paclitaxel and anti-VEGF siRNA by tripeptide lipid nanoparticle to enhance the anti-tumor activity for lung cancer therapy
Release Time:2022-12-14 Hits:
Date of Publication: 2022-10-05
Journal: DRUG DELIVERY
Volume: 27
Issue: 1
Page Number: 1397-1411
ISSN: 1071-7544
Prev One:Colorimetric and ratiometric fluorescent chemosensor with a large red-shift in emission: Cu(II)-only sensing by deprotonation of secondary amines as receptor conjugated to naphthalimide fluorophore
Next One:Co-delivery of paclitaxel and survivin siRNA with cationic liposome for lung cancer therapy